By Dr John Doan

Journal articles

Shon IH; Kumar D; Schreuder M; Guille J; Doan J; Sathikumar C; Van K; Chicco A; Hogg PJ, 2022, 'Preclinical Assessment of [⁶⁸Ga]Ga-Cell Death Indicator (CDI): A Novel hsp90 Ligand for Positron Emission Tomography of Cell Death', Current Radiopharmaceuticals, 15, pp. 184 - 193, http://dx.doi.org/10.2174/1874471014666211122100646

Di Marco L; Zhang JZ; Doan J; Kim BJ; Yamamoto N; Bryce NS; Hambley TW, 2019, 'Modulating the Cellular Uptake of Fluorescently Tagged Substrates of Prostate-Specific Antigen before and after Enzymatic Activation', Bioconjugate Chemistry, 30, pp. 124 - 133, http://dx.doi.org/10.1021/acs.bioconjchem.8b00792

Roberts MP; Pham TQ; Doan J; Jiang CD; Hambley TW; Greguric I; Fraser BH, 2015, 'Radiosynthesis and 'click' conjugation of ethynyl-4-[¹⁸F]fluorobenzene - An improved [¹⁸F]synthon for indirect radiolabeling', Journal of Labelled Compounds and Radiopharmaceuticals, 58, pp. 473 - 478, http://dx.doi.org/10.1002/jlcr.3354

Conference Papers

Mattner F; Hung T-T; Bourdier T; Lee B; Henderson D; Poon J; Doan J; Power C; Katsifis A; Fulham M, 2015, 'Evaluation of F-18-TSPO radiotracers in a prostate tumour model using PET', in JOURNAL OF NUCLEAR MEDICINE, SOC NUCLEAR MEDICINE INC, MD, Baltimore, presented at Annual Meeting of the Society-of-Nuclear-Medicine-and-Molecular-Imaging, MD, Baltimore, 06 June 2015 - 10 June 2015, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000358738801206&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Back to profile page